Literature DB >> 20920493

Neural mechanisms mediating circadian phase resetting by activation of 5-HT(7) receptors in the dorsal raphe: roles of GABAergic and glutamatergic neurotransmission.

Marilyn J Duncan1, Matthew R Congleton.   

Abstract

5-HT(7) receptors in the dorsal raphe nucleus (DRN) influence circadian rhythms, sleep, and serotonin release. Because interactions between 5-HT(7) receptors and glutamatergic and GABAergic neurons have been demonstrated previously, the current studies tested the hypothesis that GABAergic and/or glutamatergic neurons mediate phase shifts induced by activation of DRN 5-HT(7) receptors. Hamsters were fitted with guide cannulae aimed at the DRN, housed in cages with running wheels, and exposed to 14h light (L):10h dark (D). In Experiment 1, hamsters received DRN pretreatment with muscimol (87.6 pmol) or vehicle before DRN 8-OH-DPAT (6 pmol) microinjections at ZT6. After exposure to constant darkness (10 days), phase shifts were calculated and animals were re-exposed to 14L:10D. The procedure was repeated to give each animal the alternate pretreatment. In Experiment 2, hamsters received DRN pretreatment with NMDA (20 pmol) or vehicle before 8-OH-DPAT at ZT 6. Other experiments tested the effects of single DRN microinjections of muscimol, bicuculline (136 pmol), NMDA, MK-801 (10 pmol) or vehicle. Phase shifts (mean ± S.E.M., h) in muscimol/8-OH-DPAT-microinjected hamsters (1.02 ± 0.30) were not different (P=0.11) from those in vehicle/8-OH-DPAT-microinjected hamsters (1.34 ± 0.30), while those in NMDA/8-OH-DPAT-microinjected hamsters (0.67 ± 0.17) were smaller (P<0.05) than those in vehicle/8-OH-DPAT-microinjected hamsters (0.97 ± 0.10). DRN single microinjections of bicuculline, but not muscimol, NMDA, or MK-801 induced phase advances. Bicuculline also potentiated 8-OH-DPAT-induced phase advances (P<0.05). These finding suggest that the mechanism mediating DRN 5-HT(7) receptor induction of phase advances involves decreased glutamatergic neurotransmission, and furthermore, that inhibition of DRN GABAergic neurotransmission causes a phase advance.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920493      PMCID: PMC2993770          DOI: 10.1016/j.brainres.2010.09.103

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  46 in total

1.  Electrical stimulation of the median or dorsal raphe nuclei reduces light-induced FOS protein in the suprachiasmatic nucleus and causes circadian activity rhythm phase shifts.

Authors:  E L Meyer-Bernstein; L P Morin
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei.

Authors:  Rui Tao; Sidney B Auerbach
Journal:  Brain Res       Date:  2003-01-24       Impact factor: 3.252

3.  Regulation of serotonin release in the Syrian hamster intergeniculate leaflet region.

Authors:  Gregory H Grossman; Laure Farnbauch; J David Glass
Journal:  Neuroreport       Date:  2004-01-19       Impact factor: 1.837

4.  Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines.

Authors:  O Van Reeth; F W Turek
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.

Authors:  B N Smith; P J Sollars; F E Dudek; G E Pickard
Journal:  J Biol Rhythms       Date:  2001-02       Impact factor: 3.182

6.  Circadian clock resetting by sleep deprivation without exercise in the Syrian hamster.

Authors:  M C Antle; R E Mistlberger
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

7.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.

Authors:  M Guscott; L J Bristow; K Hadingham; T W Rosahl; M S Beer; J A Stanton; F Bromidge; A P Owens; I Huscroft; J Myers; N M Rupniak; S Patel; P J Whiting; P H Hutson; K C Fone; S M Biello; J J Kulagowski; G McAllister
Journal:  Neuropharmacology       Date:  2005-03       Impact factor: 5.250

8.  Circadian clock resetting by arousal in Syrian hamsters: the role of stress and activity.

Authors:  R E Mistlberger; M C Antle; I C Webb; M Jones; J Weinberg; M S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-07-03       Impact factor: 3.619

9.  SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats.

Authors:  David R Thomas; Sergio Melotto; Mario Massagrande; Andrew D Gribble; Phillip Jeffrey; Alexander J Stevens; Nigel J Deeks; Peter J Eddershaw; Susan H Fenwick; Graham Riley; Tania Stean; Claire M Scott; Matthew J Hill; Derek N Middlemiss; Jim J Hagan; Gary W Price; Ian T Forbes
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

10.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

View more
  8 in total

1.  Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans.

Authors:  R Bravo; S Matito; J Cubero; S D Paredes; L Franco; M Rivero; A B Rodríguez; C Barriga
Journal:  Age (Dordr)       Date:  2012-05-24

2.  Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission.

Authors:  Sarah Delcourte; Erika Abrial; Adeline Etiévant; Renaud Rovera; Jørn Arnt; Michael Didriksen; Nasser Haddjeri
Journal:  CNS Neurosci Ther       Date:  2017-04-17       Impact factor: 5.243

3.  Age-related differences of γ-aminobutyric acid (GABA)ergic transmission in human colonic smooth muscle.

Authors:  Maria Grazia Zizzo; Adele Cicio; Stefania Raimondo; Riccardo Alessandro; Rosa Serio
Journal:  Neurogastroenterol Motil       Date:  2021-08-25       Impact factor: 3.960

4.  Role of GABAA receptors in dorsal raphe nucleus in stress-induced reinstatement of morphine-conditioned place preference in rats.

Authors:  Chen Li; Daniel R Staub; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2013-06-28       Impact factor: 4.530

Review 5.  Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  CNS Spectr       Date:  2013-08-01       Impact factor: 3.790

6.  Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity.

Authors:  Jonathan Shelton; Sujin Yun; Susan Losee Olson; Fred Turek; Pascal Bonaventure; Curt Dvorak; Timothy Lovenberg; Christine Dugovic
Journal:  Front Behav Neurosci       Date:  2015-01-15       Impact factor: 3.558

Review 7.  The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.

Authors:  Sheketha R Hauser; Peter B Hedlund; Amanda J Roberts; Youssef Sari; Richard L Bell; Eric A Engleman
Journal:  Front Neurosci       Date:  2015-01-13       Impact factor: 4.677

8.  Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons.

Authors:  Maryam S Vasefi; Kai Yang; Jerry Li; Jeff S Kruk; John J Heikkila; Michael F Jackson; John F MacDonald; Michael A Beazely
Journal:  Mol Brain       Date:  2013-05-14       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.